Registration fees - Behcet 2018 Rotterdam

Scientific Programme

Scientific Programme

Friday 14 September 2018

08:00 - 09:30 Breakfast session hosted by Novartis Pharma – 'IL-1 in Autoinflammatory Diseases' - van Weelde Zaal
                        Chairs Martin van Hagen & Haner Direskeneli
                        08.00 Basics of autoinflammatory disease - Prof.dr. Joost Frenkel (Netherlands)
                        08.30 Hereditary Recurrent Fever syndromes-latest developments in standard of care - Prof.dr. Fabrizio de Benedetti (Italy)
                        09.00 Role of autoinflammation in Behçet's Disease - Prof.dr. Ahmet Gül (Turkey)

 09:30 - 09:45     Coffee and tea break 

09:45 - 10:30      SESSION 3 Debate 'Nature or Nurture': Does migration change the prevalence of BD? 
                             Haner Direskeneli versus Yohei Kirino
                             Moderators Alfred Mahr & Pietro Leccesse

10:30 - 11:00       Oral presentations  - Session 3
                              Chairs Cailin Sibley & Tijani Taktak
                             10:30 - 10:40 (O05) Clustering analysis of Japanese Behçet's disease identifies intestinal type as distinct cluster -                                          Y. Soejima
                             10:40 - 10:50 (O06) Disease activity and quality-of-life improvements in patients with Behçet's syndrome: a phase III                                      randomized, placebo-controlled, double-blind study of apremilast (RELIEF) - G. Hatemi
                             10:50 - 11:00 (O07) Pediatric Behcet's Disease; Report of 204 cases from the Iran registry of Behcet's disease -                                              Prof. F. Shahram, MD

11:00 - 11:30       Coffee and tea break

11:30 - 13:10       SESSION 4 - Clinical session 1 - 'Organ involvement in BD'
                              Chairs Emire Seyahi & Andreas Altenburg

                            11:30 - 11:50 Skin - Bing Thio (Netherlands)
                            11:50 - 12:10 Oral - Farida Fortune (UK)
                            12:10 - 12:30 Eye - Ilknur Tugal-Tutkun (Turkey)
                            12:30 - 12:50 Neurology - Gulsen Akman-Demir (Turkey)
                            12:50 - 13:10 Large vessel vasculitis - David Saadoun (France)

13:10 - 14:40      Celgene sponsored lunch symposium - 'Towards optimized therapeutic strategies for Behçet's syndrome:
                             applying meaningful outcome measures and treatment recommendations' - van Weelde zaal
                            13:10–13:15   Opening statements - Chairperson: Professor Gulen Hatemi (Turkey)
                            13:15–13:25   Applying the EULAR updates to clinical practice - Professor Gulen Hatemi (Turkey) 
                            13:25–14:10   Management of organ-specific manifestations - Faculty presentations followed by audience Q&A
                                                      - Mucocutaneous and joint manifestations - Professor Gulen Hatemi (Turkey)
                                                      - Gastrointestinal manifestations - Professor Aykut Celik (Turkey)
                                                      - Vascular manifestations - Professor David Saadoun (France)
                             14:10–14:35   OMERACT: working towards comparable clinical trials with the implementation of
                                                       standardized outcome measures
                                                       - Methods and latest results - Professor Gulen Hatemi (Turkey)
                                                       - Potential outcomes for gastrointestinal, vascular and mucocutaneous involvements -
                                                         Professor Gulen Hatemi / Professor David Saadoun / Professor Aykut Celik
                                                       - Panel discussion and audience Q&A - Facilitated by Professor Gulen Hatemi (Turkey)
                             14:35–14:40    Summary and close - Chairperson: Professor Gulen Hatemi (Turkey)

14:40 - 15:40       Poster tour 2 - Session ‘Clinical and Outcome Measures ‘

15:40 - 16:40       SESSION 5 - Clinical session 2 'Capita Selecta in BD'
                               Chairs Isabelle Koné-Paut & Mirjam van Velthoven
                               15:40 - 16:00 Pregnancy in patients with BD - Eldad Ben-Chetrit (Israel)
                               16:00 - 16:20 Behçet's disease in children - Annet van Royen (Netherlands)
                               16:20 - 16:40 Inflammation and surgery in BD - Dorian Haskard (UK)

16:40 - 17:10       Oral presentations - session 4
                              Chairs Shigeaki Ohno & Miles Stanford
                              16:40 - 16:50 (O08) Behcet's Uveitis: Comparison of Interferon-a vs. anti-TNF-a therapy in a clinical cohort -                                                        Dr. T. Missotten MD
                              16:50 - 17:00 (O09) Venous vessel wall thickness in lower extremity is increased in male Behcet's Disease                                                          patients - F. Alibaz-Oner
                              17:00 - 17:10  (O10) The Association of Alpha-Melanocyte Stimulating Hormone, Vasoactive Intestinal Peptide with                                        Fatigue and Quality of Sleep in Behçet's Disease - A. Senusi

17:10 - 18:30     General Assembly

19:30 - 22.30     Social dinner - Spido boat